Location History:
- Hackensack, NJ (US) (2011)
- Bronx, NY (US) (2012)
Company Filing History:
Years Active: 2011-2012
Title: The Innovative Contributions of Seth Elliott Snyder
Introduction
Seth Elliott Snyder is a prominent inventor based in the Bronx, NY. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of integrin inhibitors. With a total of 2 patents to his name, Snyder's work is recognized for its potential therapeutic applications.
Latest Patents
Snyder's latest patents include groundbreaking research on inhibitors of the α2β1/GPIa-IIa integrin. These novel compounds are designed to inhibit the integrin α2β1/GPIa-IIa receptor, which plays a crucial role in various biological processes. The patents also disclose pharmaceutical compositions containing these compounds, along with methods for their therapeutic use. Additionally, he has developed inhibitors of integrin alpha2beta1 with a modified urea moiety, further expanding the potential applications of his research in medical treatments.
Career Highlights
Snyder is affiliated with the University of Pennsylvania, where he continues to advance his research in integrin inhibitors. His work has garnered attention for its innovative approach to addressing complex medical challenges.
Collaborations
Snyder has collaborated with notable colleagues, including William F. DeGrado and Joel S. Bennett. These partnerships have enriched his research and contributed to the development of effective therapeutic solutions.
Conclusion
Seth Elliott Snyder's contributions to the field of pharmaceutical sciences through his innovative patents highlight his role as a leading inventor. His work on integrin inhibitors showcases the potential for significant advancements in therapeutic applications.